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Abstract
Background Hyperhomocysteinemia is implicated in the
pathogenesis of various liver diseases. In this study, the
effects of S-adenosylmethionine (SAM) on hyperhomocy-
steinemia and steatosis with ethanol-induced liver injury in
rats were examined and their mechanisms were explored.
Methods Forty-eight female Sprague–Dawley rats were
randomly divided into four groups as control, model, low-
dose, and high-dose SAM groups. Except the control
group, all rats were fed high-fat-containing diet plus eth-
anol and ﬁsh oil gavaged for 8 weeks. SAM was
administered by intraperitoneal injection after the 4 weeks’
exposure of ethanol. Serum homocysteine (Hcy), alanine
aminotransferase (ALT), aspartate aminotransferase
(AST), total cholesterol (TC), triglyceride (TG), tumor
necrosis factor a (TNF-a), and transforming growth factor
b1 (TGF-b1) levels were determined. The contents of liver
malondialdehyde (MDA) and glutathione (GSH) were
assayed. Liver histology was also examined. The expres-
sions of TNF-a and TGF-b1 mRNAs in the liver were
detected by the reverse transcriptase-polymerase chain
reaction assay.
Results Compared with the control group, the model
group rats developed marked liver damage, accompanied
by an increase in Hcy, ALT, AST, TC, TG, TNF-a, TGF-
b1, and MDA levels. However, the levels of GSH were
decreased. These responses were associated with the
increased expression of TNF-a and TGF-b1 mRNAs in the
livers, as well as the existence of hepatocellular necrosis
and neutrophil inﬁltration in the livers. In treatment groups,
SAM provided signiﬁcant protection from the liver injury
induced by alcohol, resulting in a decrease in serum TNF-
a, TGF-b1 levels, lipid peroxidation, and the expressions of
TNF-a and TGF-b1 mRNAs in the livers, as well as an
increase in GSH levels. However, no statistical difference
was observed in these parameters between the two different
dose treatment groups. In the study, SAM did not affect
plasma total homocysteine (tHcy) levels signiﬁcantly.
Conclusion SAM prevents alcohol-induced liver injury in
rats by reducing liver lipid peroxidation, anti-inﬂammation,
and antihyperplasia. In addition, it does not affect the
plasma tHcy levels.
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Introduction
Hyperhomocysteinemia is a common event in patients with
liver diseases, especially in cases with alcoholic liver dis-
ease and liver failure. It has been implicated in the
pathogenesis of these diseases. Increased homocysteine
(Hcy) is one of the most important causes of endoplasmic
reticulum stress. It promotes lipid synthesis and accumu-
lation and induces apoptosis.
Previous studies have shown that chronic ethanol
administration alters methionine in the liver, resulting in an
increased intracellular S-adenosylhomocysteine (SAH) and
Hcy release into the plasma [1–3]. A major defect elicited
by ethanol consumption appears to be the inhibition of
methionine synthetase activity, which results in an
impaired remethylation of Hcy to form methionine [4–6].
Z. Gong (&)   S. Yan   P. Zhang   Y. Huang   L. Wang
Department of Infectious Diseases, State Key Laboratory of
Virology, Renmin Hospital of Wuhan University, Wuhan
430060, China
e-mail: zjgong@163.com
123
Hepatol Int (2008) 2:346–352
DOI 10.1007/s12072-008-9082-1Ethanol consumption also increases the intracellular levels
of SAH [7]. SAH is the metabolic precursor of Hcy and is
formed as a product of methyl transfer reactions involving
S-adenosylmethionine (SAM) [8–10]. Hcy is removed
inefﬁciently during ethanol administration and with the
impaired methionine synthetase activity. An increased
accumulation of intracellular SAH eventually affects the
activity of a number of methyltransferases. A special SAM-
dependent liver methyltransferase, phosphatidylethenol-
amine-N-methyl transferase (PEMT), which generates
phosphatidylcholine (PC) from phosphatidylethanolamine
via methylation, is especially susceptible [11]. It was
reported recently that the generation of PC by the PEMT
pathway is an obligatory event in the synthesis and secre-
tion of very low-density lipoprotein [12]. This process is
essential for lipid export from the liver. A defect in the PC
generation via the PEMT pathway could, therefore, lead to
abnormal lipid accumulation in the hepatocyte. Further-
more, proinﬂammatory cytokines such as tumor necrosis
factor a (TNF-a) and transforming growth factor b
(TGF-b) play important roles in ethanol-induced liver
injury. SAM is an essential metabolite in all cells and
serves mainly as a methyl donor for many methylation
reactions. It has even been used as a therapeutic agent in
many toxin-induced liver injuries including those induced
by alcohol [13]. The mechanism of their beneﬁcial effects
has not been clariﬁed yet. The aim of this study was to
investigate the efﬁcacy of SAM in ameliorating ethanol-
induced injury by improving methionine metabolism and
steatosis in experimental rats.
Materials and methods
Chemicals and reagents
SAM (500 mg/amp) was kindly gifted by Knoll Pharma-
ceutical SPA Ltd. (Liscate, Italy). Ferrous sulfate was
purchased from Shanghai Reagent Chemicals Co. Ltd
(Shanghai, China). Hcy assay kit was purchased from
Sigma–Aldrich Co. (USA). Enzyme-linked immunosorbent
assay (ELISA) kits for rat TNF-a and TGF-b detection
were purchased from Shanghai Senxiong Biotech Industry
Co. Ltd (Shanghai, China). Malondialdehyde (MDA) and
glutathione (GSH) assay kits were purchased from Nanjing
Jiancheng Bioengineering Co. Ltd (Nanjing, China). TRI-
zol reagent was purchased from Invitrogen Co. (USA).
DL1000 DNA ladder marker was purchased from TaKaRa
Biotech Co. Ltd (Japan). M-MLV reverse transcriptase,
deoxyribonucleotide (dNTP, 10 mM), oligo (dT)15 primer,
Taq DNA polymerase, and RNasin were purchased from
Promega Biotech Co. Ltd (USA). Polymerase chain reac-
tion (PCR) primers for TNF-a, TGF-b, and GAPDH were
synthesized by Sai-Bai-Sheng Biocompany (Shanghai,
China).
Animal models
Forty-eight female Sprague–Dawley rats, weighing 100–
150 g, were obtained from the Experimental Animal Center
of Wuhan University. After acclimation for 6–7 days,
animals were randomly divided into four groups as control,
model, low-dose, and high-dose SAM groups, with each
group containing 12 rats. Except the control group, which
was fed with ordinary diet and received an intragastric
administration of physiological saline, other three groups
were fed with ordinary foods with added fat-rich diet of
lard and whole milk powder (80:10:10) and were admin-
istrated intragastrically with ethanol and 0.5 ml ﬁsh oil.
The initial dose of ethanol was 6 g kg
-1 day
-1 (solutions
maximally containing 56% alcohol), and the dose was
progressively increased during week 1 to a maintenance
dose of 8 g kg
-1 day
-1, which was continued for 8 weeks.
SAM was administrated (100 and 200 mg kg
-1) by intra-
peritoneal injection after exposure to ethanol for 4 weeks.
Animals were weighed thrice per week. At the end of the
experiment, animals were anesthetized with 20% urethane
(1.0 g kg
-1) and killed humanely by bleeding from femoral
arteries. Blood and liver samples were collected for further
examinations. All animals were given humane care in
compliance with the institutional guidelines.
Histological examination
The liver specimens were ﬁxed in 10% formaldehyde for
12 h, embedded in parafﬁn, sliced into 5-lm thick sections,
and stained with hematoxylin-eosin. Histological assess-
ments were performed blindly by two independent
pathologists. The severity of steatosis was evaluated as 0
(no hepatocytes), 1 (\25% of hepatocytes), 2 (26–50% of
hepatocytes), 3 (51–75% of hepatocytes), and 4 ([75% of
hepatocytes). The necroinﬂammatory scores were evalu-
ated as 0 (none), 1 (minimal), 2 (mild), 3 (moderate), and 4
(severe) on the basis of the degree of portal and lobular
inﬂammation and the evidence of piecemeal and spotty
necrosis.
Plasma total Hcy assay
Blood samples were collected in EDTA-containing tubes
and centrifuged at 2,500g for 10 min, and the plasma was
isolated and stored at -20C. The plasma level of total Hcy
(tHcy) was assessed using Waters 2475 high-performance
liquid chromatograph according to the assay described by
Mourvaki et al. [14].
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123Biochemistry and determination of serum TNF-a
and TGF-b1
Serum alanine aminotransferase (ALT), aspartate amino-
transferase (AST), triglyceride (TG), and total cholesterol
(TC) were determined by routine laboratory methods using
a Hitachi Automatic Analyzer (Hitachi, Inc., Japan). Serum
levels of TNF-a and TGF-b1 were measured using a
commercial kit (Shanghai Senxiong Biotech Industry Co.
Ltd, Shanghai, China) by sandwich ABC-ELISA according
to the manufacturer’s instructions.
Determination of liver MDA and GSH
Liver samples were thawed, weighed, and homogenized at
a ratio of 1:9 (w/v) in 0.9% saline solution. The homoge-
nates were centrifuged at 3,000 rpm for 10 min at 4C. The
supernatant was used for the determination of MDA, GSH,
and total protein. MDA was assayed by spectrophotometric
analysis for the levels of thiobarbituric acid-reactive sub-
stances at a wavelength of 532 nm. The values were
expressed in nmol mg
-1 protein. Total GSH activities were
also measured by spectrophotometric analysis. The absor-
bance was measured at 530 nm. The activities of GSH were
calculated and expressed as U mg
-1 protein. Total protein
concentration was determined using the Coomassie Blue
method, with bovine serum albumin as the standard.
Detection of liver TNF-a and TGF-b1 mRNAs
Liver total RNAs were isolated by using the Catrimox-14
TM RNA puriﬁcation kit (Takara Bio Inc, Japan). RNA
concentrations were determined by spectrophotometric
measurements at wavelengths of 260/280 nm. One micro-
gram of RNA was transcribed into complementary DNA
(cDNA) using AMV reverse transcriptase (Takara Bio Inc.,
Japan). The cDNA was ampliﬁed by PCR assay. The
ampliﬁcation primers for rat TNF-a were 50-GCCAATGG
CATGGATCTCAAAG-30 and 50-CAGAGCAATGACTC
CAAA-30, for rat TGF-b1 were 50-CACCATCCATGACA
TGAACC-30 and 50-TCATGTTGGACAACTGCTCC-30,
and for rat GADPH were 50-TCCCTCAAGATTGTCAGC
AA-30 and 50-AGATCCACAACGGATACATT-30,r e s -
pectively. A 50 ll of PCR reaction mix contained 10 mM
of dNTP, 2.5 mM of MgCl2, 20 mM of Tris–HCl (pH 8.4),
50 mM of KCl, 25 pM of sense and antisense primers, and
2 U of Taq DNA polymerase. Ampliﬁcation was performed
for 35 cycles with initial incubation at 94C for 3 min and
ﬁnal extension at 72C for 7 min, with each cycle consisting
of denaturation for 45 s at 94C, annealing for 45 s at 54C,
and extension for 1 min at 72C. The PCR products were
357, 404, and 309 bp for TNF-a,T G F - b1, and GADPH,
respectively. In all experiments, possible contamination with
genomic DNA was excluded by PCR ampliﬁcation in the
absence of reverse transcriptase. The PCR products were
electrophoresed on a 2% agarose gel. Semiquantitative eval-
uation was performed by using the Gel Doc 2000 System
(BioRad Laboratories GmbH, Munchen, Germany). GADPH
was used as a positive internal control and was found to be
positive for each specimen. Its expression was used as a cor-
rectionfactorforTNF-aandTGF-b1mRNAs;thus,theresults
were calculatedas the ratio of theintensity ofbands ofTNF-a
and TGF-b1 cDNA per GADPH cDNA on the gel.
Statistical analysis
All data were presented as means ± SEM. Differences
among groups were assessed by using unpaired Student
t-test and one-way analysis of variance. P-values of less
than 0.05 were considered to be statistically signiﬁcant.
Calculations were performed with the SPSS, Version 11.0,
statistical software package.
Results
Changes in liver histology
The control group developed slight steatosis in the liver,
but obvious inﬂammation or necrosis was not observed
(Fig. 1a). In the model group, the rats developed hepato-
cyte steatosis, minimal to mild inﬂammation, and necrosis
in the liver (Fig. 1b). However, both hepatocyte steatosis
and inﬂammation were markedly reduced in the rats treated
with low and high doses of SAM, except that only few fat
vacuoles and inﬂammatory cells were observed (Fig. 1c,
d). Liver steatosis scores and necroinﬂammatory scores in
each group are referred in Table 1.
Effects of SAM on plasma tHcy, liver function,
and blood fat levels
As shown in Table 2, the levels of plasma tHcy and serum
ALT, AST, TG, and TC were signiﬁcantly increased in the
model group when compared with the control group. But
there is no statistical difference in the levels of plasma
tHcy between the model and the SAM treatment groups.
Compared with the model groups, the levels of serum ALT,
AST, TG, and TC signiﬁcantly decreased in the SAM-
treated rats.
Effects of SAM on TNF-a, TGF-b, MDA, and GSH
As shown in Table 3, ethanol administration caused serum
levels of TNF-a and TGF-b1 to markedly increase in the
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123model group, but SAM administration could inhibit their
increased levels after alcohol exposure. Compared with the
normal group, liver MDA signiﬁcantly increased in the rats
of model group. However, SAM administration markedly
blunted the increases of liver MDA. No difference existed
in the contents of liver MDA between the SAM and the
normal groups. Chronic ﬁsh oil plus ethanol gavage led to a
marked reduction of GSH activity in the rats of model
group, while SAM could signiﬁcantly elevate the GSH
activity.
Fig. 1 Histological
examinations of the liver: (a)
normal group, (b) model group,
(c) low-dose SAM group, and
(d) high-dose SAM group.
Magniﬁcation, 2009
Table 1 Liver necroinﬂammatory scores and steatosis scores
Groups n Inﬂammation scores Necrosis scores Steatosis necrosis
Normal control 12 0.224 ± 0.115
a 0.061 ± 0.043
a 0.304 ± 0.056
a
Model 12 2.963 ± 0.393 0.989 ± 0.254 3.372 ± 0.237
Low-dose SAM 12 0.331 ± 0.123
a 0.074 ± 0.026
a 0.351 ± 0.032
a
High-dose SAM 12 0.301 ± 0.227
a 0.069 ± 0.135
a 0.346 ± 0.106
a
a Compared with model group, P\0.01
b Compared with model group, P\0.05
SAM, S-adenosylmethionine
Table 2 Detections of plasma tHcy, liver function, and blood fat levels
Groups n tHcy (mmol l
-1) ALT (U l
-1) AST (U l
-1) TC (mmol l
-1) TG (mmol l
-1)
Normal control 12 11.36 ± 1.27
a 57.18 ± 1.99
a 215.56 ± 1.59
a 2.22 ± 0.25
a 0.35 ± 0.49
a
Model 12 24.64 ± 2.47 157.62 ± 2.29 247.78 ± 1.93 15.61 ± 0.36 2.4 ± 0.18
Low-dose SAM 12 23.30 ± 3.34
c 64.35 ± 1.62
a 189.39 ± 6.45
a 3.53 ± 0.29
a 0.57 ± 0.20
a
High-dose SAM 12 22.45 ± 2.66
c 63.75 ± 2.85
a 187.50 ± 5.54
a 3.49 ± 0.32
a 0.54 ± 0.31
a
a Compared with model group, P\0.01
b Compared with model group, P\0.05
c Compared with model group, P[0.05
ALT, alanine aminotransferase; AST, aspartate aminotransferase; SAM, S-adenosylmethionine; tHyc, total homocysteine; TC, total cholesterol;
TG, triglyceride
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123Effects of SAM on expressions of liver TNF-a
and TGF-b1 mRNAs
As shown in Fig. 2a, c, TNF-a and TGF-b1 mRNAs were
barely detectable in the liver of control group rats, but after
chronic ethanol gavages, the expressions of TNF-a and
TGF-b1 mRNAs were markedly induced. SAM adminis-
tration could obviously inhibit the expressions of TNF-a
and TGF-b1 mRNAs in the rats of alcohol exposure group.
Discussion
At present, the most prevalent injury to the liver is induced
by alcohol. However, its exact pathogenesis remains
unclear. Hyperhomocysteinemia resulting from the disor-
der of methionine metabolism may play an important role
in alcohol-induced liver injury [15]. The results of our
study showed that the levels of plasma tHcy were signiﬁ-
cantly increased in the rats of model group compared with
the control group. It is suggested that the disorders of
methionine metabolism existed in alcohol-induced liver
injury.
The results of our study also showed that the levels of
plasma tHcy in both low-dose and high-dose SAM treat-
ment groups could not be reduced compared with the
model group. SAM could not improve hyperhomocystein-
emia caused by alcohol-induced liver injury. However, the
levels of serum ALT, AST, TG, and TC signiﬁcantly
decreased in the rats of SAM treatment groups when
compared with the model groups. SAM could obviously
improve liver injury induced by alcohol. The probable
mechanisms were that SAM could decrease plasma levels
of SAH, and thereby lead to an increase in the ratio of
SAM and SAH, which could provide an active methyl
donor for the normal methionine circulation for human
body, eventually it could prevent the accumulation of SAH
[16].
A lot of evidence showed that mediators of inﬂamma-
tion and cytokine play an important role in ethanol-induced
liver injury, in which TNF-a may be the key factor
[17, 18]. The results of our study also conﬁrmed that
Table 3 Detection of TNF-a, TGF-b1, MDA, and GSH
Groups n TNF-a (pg ml
-1) TGF-b1 (pg ml
-1) MDA (nmol mg
-1 protein) GSH (mg mg
-1 protein)
Normal control 12 3.84 ± 0.12
a 20.45 ± 1.36
a 2.82 ± 0.16
a 26.87 ± 2.33
a
Model 12 4.67 ± 0.19 26.39 ± 1.21 6.69 ± 0.34 11.38 ± 1.98
Low-dose SAM 12 4.19 ± 0.40
b 25.09 ± 0.83
b 1.65 ± 0.51
a 19.50 ± 1.77
a
High-dose SAM 12 4.05 ± 0.58
b 24.46 ± 0.50
b 1.63 ± 0.17
a 20.47 ± 0.85
a
a Compared with model group, P\0.01
b Compared with model group, P\0.05
GSH, glutathione; MDA, malondialdehyde; SAM, S-adenosylmethionine; TGF-b1, transforming growth factor b1; TNF-a, tumor necrosis factor a
Fig. 2 RT-PCR analysis of
expressions of TNF-a mRNA
and TGF-b1 mRNA. (a) TNF-a
mRNA, (b) GAPDH mRNA, (c)
TGF-ß1 mRNA, (d) GAPDH
mRNA. Lane 1 represents
normal group, lane 2 represents
model group, lane 3 represents
low-dose SAM group, and lane
4 represents high-dose SAM
group. M represents molecular
size marker
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123ethanol administration caused serum levels of TNF-a to
markedly increase in the rats of model group. We further
observed that SAM administration could obviously inhibit
the expressions of TNF-a mRNA and decrease the serum
levels of TNF-a in the rats with alcohol exposure. It may be
one of the reasons why SAM could protect liver injury
induced by alcohol administration.
TGF-b1 could induce the formation of extracellular
matrix and inhibit the degradation of extracellular matrix,
which could lead to the development of hepatic ﬁbrosis.
With frequent inﬂammation and ﬁbrosis, alcoholic
cirrhosis could ﬁnally emerge [19]. Therefore, downreg-
ulation of the expression of TGF-b1 could delay the
proceeding of hepatic ﬁbrosis by preventing the apoptosis
of hepatocyte and activation of hepatic stellate cells. The
results of our study showed that ethanol administration
caused serum levels of TGF-b1 to markedly increase in
the rats of model group, while SAM administration could
obviously inhibit the expressions of TGF-b1 mRNA, as
well as decrease the serum levels of TGF-b1 in the rats
with alcoholic exposure. It is suggested that SAM had
much effect on antihepatic ﬁbrosis. The probable mech-
anisms could be that SAM blocked the production of
collagen I by preventing TGF-b1 to induce the COL1A2
promoter of collagen I [20]. Furthermore, 50-methylthio-
adenosine, a product of SAM catabolism, could prevent
upregulation of TGF-b1[ 21].
Alcohol and its metabolite, such as acetaldehyde and
fatty acids, could generate a large amount of reactive
oxygen species (ROS) in the course of metabolism by
cytochrome p450 2E1 of microsomes. ROS could damage
hepatocytes directly as well as by enhancing the sensitivity
of hepatocytes to lipid peroxidation [22, 23]. GSH is the
important reducing agent in our body, which plays a key
role against the toxic effects of ROS. Our study showed
that liver MDA, a marker of lipid peroxidation, signiﬁ-
cantly increased in the rats of model group that had ethanol
gavages for 8 weeks when compared with normal groups.
However, SAM administration markedly blunted the rises
of liver MDA. Furthermore, chronic ﬁsh oil plus ethanol
gavages led to an obvious reduction of GSH activity in the
rats of model group, while SAM could signiﬁcantly elevate
the GSH activity. Thus, SAM could increase the contents
of GSH in liver microsomes and inhibit the production of
MDA, which could enhance the ability for clearance of free
radical and its metabolite, inhibit the reaction of lipid
peroxidation, reduce the damages from free radicals, and
protect hepatocytes.
In summary, the results of our studies indicated that
SAM could prevent ethanol-induced liver injury in rats by
modulating the system of oxidants and antioxidants in the
liver, but did not affect the plasma levels of tHcy.
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